Back to search
CPSCCPSC · Consumer products·Recall number 21089

Imatinib Mesylate Tablets 100 mg, Imatinib Mesylate Tablets 400 mg, Pregabalin Capsules 50 mg, Pregabalin Capsules 75 mg, Pregabalin Capsules 100 mg, Pregabalin Capsules 150 mg, Sevelamer Carbonate Tablets 800 mg, Tadalafil Tablets 5 mg and Tadalafil Tablets 20 mg

Published February 25, 2021

Summary

CPSC records recall 21089, published February 25, 2021. Recalling firm: Dr. Reddy's Laboratories, Ltd., of India; Reported units: About 21,400.

What's the hazard

The products are prescription medications that were labeled and distributed by Dr. Reddy's for institutional use only. The prescription medications were distributed by third party wholesalers to retail pharmacies and could have been dispensed to consumers. The packaging of the products is not child resistant and can pose a risk of poisoning if the contents are swallowed by young children.

What to do

Consumers should immediately store the recalled medications in a safe location out of reach of children and contact Dr. Reddy's for a full refund.

Get an email if Dr. Reddy's Laboratories has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
Dr. Reddy's Laboratories, Ltd., of India
Manufacturer
Dr. Reddy's Laboratories, Ltd., of India
Distributor
Beginning in 2018, Dr. Reddy's sold the recalled medications to wholesalers. Ultimately, these medications could have been sold to consumers at retail pharmacies in the United States at prices varying based on quantities prescribed, health insurance terms, and other factors.
Country
US

Related recalls

Questions about this recall

Was Imatinib Mesylate Tablets 100 mg, Imatinib Mesylate Tablets 400 mg, Pregabalin Capsules 50 mg, Pregabalin Capsules 75 mg, Pregabalin Capsules 100 mg, Pregabalin Capsules 150 mg, Sevelamer Carbonate Tablets 800 mg, Tadalafil Tablets 5 mg and Tadalafil Tablets 20 mg recalled?

Yes. CPSC published recall 21089 on February 25, 2021. Reported hazard: The products are prescription medications that were labeled and distributed by Dr. Reddy's for institutional use only. The prescription medications were distributed by third party wholesalers to retail pharmacies and could have been dispensed to consumers. The packaging of the products is not child resistant and can pose a risk of poisoning if the contents are swallowed by young children.

What should I do if I have this product?

Consumers should immediately store the recalled medications in a safe location out of reach of children and contact Dr. Reddy's for a full refund.

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: Dr. Reddy's Laboratories, Ltd., of India.

View official CPSC notice(opens on cpsc.gov)